retatrutide clinical trials update Retatrutide: What It Is & How This New Drug Works Retatrutide Phase 3: TRIUMPH Program

Red flags (When to Call/ER) While most GLP-1 side effects are mild and manageable, there are a few rare but serious side effects that require immediate medical attention

July 2nd, 2025: Rise in Ozempic Vision Loss Lawsuits Sparks Discussion on Broadening GLP-1 MDL Scope A growing wave of lawsuits is being filed against Novo Nordisk, alleging that its GLP-1 receptor agonist medicationsincluding Ozempic and Wegovycaused permanent vision loss due to non-arteritic anterior ischemic optic neuropathy (NAION)

Goal weight is 115-120

Before initiating JANUVIA, ask patients about a history of heart failure or other risk factors for heart failure including moderate to severe renal impairment

PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after first month) which analyzes key variants in the GLP1R gene (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) among 14 mapped pathways covering 49 peptides